TERTpromoter mutations in melanoma survival-Reference-Cited by-同舟云学术

TERTpromoter mutations in melanoma survival

Published:2016-03-02 Issue:1 Volume:139 Page:75-84
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Nagore Eduardo¹,Heidenreich Barbara²,Rachakonda Sívaramakrishna²,Garcia-Casado Zaida³,Requena Celia¹,Soriano Virtudes⁴,Frank Christoph²,Traves Victor⁵,Quecedo Esther⁶,Sanjuan-Gimenez Josefa⁷,Hemminki Kari²⁸,Landi Maria Teresa⁹,Kumar Rajiv²

Affiliation:

1. Department of Dermatology; Instituto Valenciano De Oncologia; Valencia Spain

2. Division of Molecular Genetic Epidemiology; German Cancer Research Center; Heidelberg Germany

3. Laboratory of Molecular Biology; Instituto Valenciano De Oncologia; Valencia Spain

4. Medical Oncology Department; Instituto Valenciano De Oncologia; Valencia Spain

5. Department of Pathology; Instituto Valenciano De Oncologia; Valencia Spain

6. Department of Dermatology; Hospital Arnau De Vilanova De Valencia; Valencia Spain

7. Department of Pathology; Hospital Arnau De Vilanova De Valencia; Valencia Spain

8. Center for Primary Health Care Research; Lund University; Malmö Sweden

9. Division of Epidemiology and Genetics; National Cancer Institute, US National Institutes of Health; Bethesda MD

Funder

TRANSCAN (German Ministry of Education and Science)

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference44 articles.

1. Melanoma: from mutations to medicine;Tsao;Genes Dev,2012

2. The evolution of melanoma resistance reveals therapeutic opportunities;Das Thakur;Cancer Res,2013

3. Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanoma;Long;Nat Commun,2014

4. Signatures of mutational processes in human cancer;Alexandrov;Nature,2013

5. A landscape of driver mutations in melanoma;Hodis;Cell,2012

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utility and Micro-Costing Framework for TERT Promoter Mutation Analysis in Melanocytic Lesions of Uncertain Malignant Potential: A Retrospective Study in Dutch Local Clinical Practice;Diagnostics;2024-08-01

2. Coexisting RET/PTC and TERT Promoter Mutation Predict Poor Prognosis but Effective RET and MEK Targeting in Thyroid Cancer;The Journal of Clinical Endocrinology & Metabolism;2024-05-13

3. Molecular Characterization of Advanced-Stage Melanomas in Clinical Practice Using a Laboratory-Developed Next-Generation Sequencing Panel;Diagnostics;2024-04-11

4. A multiparameter liquid biopsy approach allows to track melanoma dynamics and identify early treatment resistance;npj Precision Oncology;2024-03-28

5. TERT promoter mutations in atypical melanocytic lesions: A series of seven cases with adverse melanoma-specific outcome;Human Pathology;2024-02